We are live on ! Find out more
FCM

Frontier Capital Management Portfolio holdings

AUM $9.73B
1-Year Est. Return 55.65%
This Fund
S&P 500
This Quarter Est. Return
+12.52%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$9.18B
AUM Growth
+$653M
Cap. Flow
-$109M
Cap. Flow %
-1.19%
Top 10 Hldgs %
15.1%
Holding
285
New
17
Increased
85
Reduced
160
Closed
23

Top Buys

Rank Stock Value
1
ATI icon
ATI
ATI
+$60.5M
2
LAD icon
Lithia Motors
LAD
+$58.4M
3
LRCX icon
Lam Research
LRCX
+$37.8M
4
IRT icon
Independence Realty Trust
IRT
+$32.9M
5
INSP icon
Inspire Medical Systems
INSP
+$32.3M

Top Sells

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$104M
2
LPLA icon
LPL Financial
LPLA
+$94.5M
3
MAT icon
Mattel
MAT
+$65.6M
4
LYV icon
Live Nation Entertainment
LYV
+$42M
5
DLO icon
dLocal
DLO
+$41.6M

Sector Composition

Rank Sector Weight
1 Technology 22.59%
2 Industrials 17.82%
3 Healthcare 16.73%
4 Consumer Discretionary 15.41%
5 Financials 13.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
251
DELISTED
Seagen Inc. Common Stock
SGEN
$2.04M 0.02%
15,840
+91
+0.6% +$11.7K
CDLX icon
252
Cardlytics
CDLX
$21.7M
$2.03M 0.02%
35,133
-104
-0.3% -$6.42K
ESTC icon
253
Elastic
ESTC
$6.84B
$1.88M 0.02%
36,555
-59,622
-62% -$3.57M
ADPT icon
254
Adaptive Biotechnologies
ADPT
$3.59B
$1.41M 0.02%
184,433
+902
+0.5% +$7.02K
ENVX icon
255
Enovix
ENVX
$892M
$1.01M 0.01%
93,063
-200,249
-68% -$2.46M
CYTK icon
256
Cytokinetics
CYTK
$10.5B
$878K 0.01%
19,161
-140,053
-88% -$6.03M
CHRD icon
257
Chord Energy
CHRD
$7.9B
$718K 0.01%
5,246
-104,492
-95% -$15.3M
AA icon
258
Alcoa
AA
$11.9B
$654K 0.01%
+14,380
New +$626K
OUST icon
259
Ouster
OUST
$2.63B
$538K 0.01%
62,396
-184
-0.3% -$2K
RPD icon
260
Rapid7
RPD
$645M
$288K ﹤0.01%
8,474
+39
+0.5% +$1.39K
ARVN icon
261
Arvinas
ARVN
$518M
$256K ﹤0.01%
7,469
-18,494
-71% -$778K
FIVE icon
262
Five Below
FIVE
$12B
$233K ﹤0.01%
1,320
-58,384
-98% -$9.18M
AMED
263
DELISTED
Amedisys
AMED
-373,731
Closed -$36.2M
APLS
264
DELISTED
Apellis Pharmaceuticals
APLS
-6,193
Closed -$423K
BRX icon
265
Brixmor Property Group
BRX
$9.67B
-25,445
Closed -$470K
CVNA icon
266
Carvana
CVNA
$68.6B
-660,855
Closed -$2.68M
DLO icon
267
dLocal
DLO
$4.44B
-2,025,970
Closed -$41.6M
GH icon
268
Guardant Health
GH
$21.5B
-8,003
Closed -$431K
INSW icon
269
International Seaways
INSW
$4.76B
-257,241
Closed -$9.04M
IOVA icon
270
Iovance Biotherapeutics
IOVA
$1.82B
-382,648
Closed -$3.67M
KPTI icon
271
Karyopharm Therapeutics
KPTI
$43.5M
-41,944
Closed -$3.44M
LYFT icon
272
Lyft
LYFT
$6.02B
-1,119,621
Closed -$14.7M
MRNA icon
273
Moderna
MRNA
$21.8B
-140,948
Closed -$16.7M
PATH icon
274
UiPath
PATH
$6.61B
-30,334
Closed -$383K
ROKU icon
275
Roku
ROKU
$21.5B
-319,831
Closed -$18M

Similar funds

Frontier Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Frontier Capital Management held 285 positions worth $9.18B, up 7.7% from $8.53B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Frontier Capital Management's Q4 2022 filing shows 17 new, 85 increased, 160 reduced and 23 closed positions. Its largest new stake was Independence Realty Trust: 1,945,941 shares worth $32.8M. The largest sale was Coterra Energy, an estimated $104M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Frontier Capital Management's largest Q4 2022 buy was Independence Realty Trust: 1,945,941 shares worth $32.8M.
  • Frontier Capital Management added most to ATI in Q4 2022, an estimated $60.5M increase.
  • Frontier Capital Management's biggest Q4 2022 reduction was Coterra Energy, cutting an estimated $104M.
  • Frontier Capital Management fully exited dLocal in Q4 2022, selling an estimated $41.6M.
  • Frontier Capital Management's ten largest holdings make up 15% of its $9.18B portfolio in Q4 2022.
  • Frontier Capital Management opened 17 new positions and closed 23 in Q4 2022.
  • Frontier Capital Management's portfolio value rose 7.7% quarter-over-quarter to $9.18B.

Based on Frontier Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.